According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

According to a newly published market research report by 24LifeSciences, the global prostate cancer diagnosis and therapy market was valued at USD 17.2 billion in 2024 and is projected to reach USD 23.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 20252032. Prostate cancer, the second most common cancer in men globally, requires a...

According to a newly published market research report by 24LifeSciences, global prostate cancer treatment drugs market was valued at USD 14.03 billion in 2024 and is projected to reach USD 18.74 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Prostate cancer treatment drugs represent a critical segment in oncology therapeutics,...

According to a newly published market research report by 24LifeSciences, theglobal thymus cancer market was valued at USD 149 million in 2025 and is projected to reach USD 213 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2031. Thymus cancer, clinically referred to as thymoma or thymic carcinoma, is a rare malignancy...

The increasing burden of cancer and ophthalmic disorders is creating substantial demand for advanced therapeutic solutions worldwide. Anti-angiogenic therapies have become an important component of modern treatment strategies, particularly in oncology and retinal disease management. Continuous innovation in targeted therapies is further supporting industry expansion across developed and...

The lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...

According to a newly published market research report by 24LifeSciences, the global Small Cell Lung Cancer therapeutics market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252031. Small Cell Lung Cancer (SCLC) is an aggressive neuroendocrine malignancy accounting for...

According to a newly published market research report by 24LifeSciences, the global unresectable hepatocellular carcinoma treatment market was valued at USD 1.8 billion in 2024 and is projected to reach USD 3.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 20252032. Unresectable hepatocellular carcinoma (uHCC) refers to primary liver...